A new federal law prevents patients from being billed by out-of-network doctors after being treated in an in-network hospital. We asked Prof. Fiona Scott Morton, whose research helped bring the practice to light, what the new law will mean for patients and healthcare costs.

Prof. Andrew Metrick, director of the Yale Program on Financial Stability, says that the four emergency lending programs recently shut down by Treasury Secretary Steven Mnuchin are an insurance policy that may be badly needed in 2021.

Pfizer’s announcement that its experimental COVID-19 vaccine appears to be more than 90% effective has provided hope for relief from the increasingly calamitous onslaught of the virus. We asked Yale SOM’s Dr. Howard Forman about next steps.

Yale SOM’s Amy Wrzesniewski, an expert in how people find meaning in their jobs, says that working remotely can diminish our sense of community and structure—and offers suggestions for staying anchored.

Debilitated by COVID-19, airlines are preparing to cut more than 30,000 jobs as soon as next month. We asked Prof. Kevin Williams to explain some of the economics of air travel and how the industry can survive in an age of stay-at-home orders. 

In September, under pressure from the Trump administration to sell its U.S. operations, the Chinese-owned social media app TikTok tentatively agreed to partner with Oracle. We asked Prof. Paul Bracken, an expert on strategy and technology, about the security threat from Chinese technology companies and how the conflict might play out. 

If Joe Biden is elected this November, Kamala Harris would be the first woman and the first person of color to serve as vice president. We asked Prof. Oriane Georgeac, who studies perceptions of diversity, if Harris’s nomination heralds an acceleration of progress for women generally.

We checked in with Yale SOM’s Dr. Howard Forman about herd immunity, vaccines, and that case of reinfection in Hong Kong.

The path of the pandemic has been shaped by inequality, with poor and minority workers experiencing greater exposure to infection and fewer health protections. Has the policy response helped ease these inequities—or made them worse?